LGR5 and Nanog identify stem cell signature of pancreas beta cells which initiate pancreatic cancer

Biochemical and Biophysical Research Communications

Volumn 433, Issue 2, 2013, Pages 157-162

  Amsterdam, Abraham ^a   Raanan, Calanit ^a   Schreiber, Letizia ^b   Polin, Nava ^a   Givol, David ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b WOLFSON MEDICAL CENTER   (Israel)

Author keywords

Diabetes; Insulin; Metastasis; PDAC; Stem cells

Indexed keywords

CELL MARKER; LGR5 PROTEIN; TRANSCRIPTION FACTOR NANOG; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER TISSUE; CELL DEDIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER METASTASIS; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS FUNCTION; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; STEM CELL;

EID: 84877677222     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.02.038     Document Type: Article

References (24)

1. Hezel A.F., Kimmelman A.C., Stanger B.Z., Bardeesy N., Depinho R.A. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 2006, 20:1218-1249.
2. Balic A., Dorado J., Alonso-Gomez M., Heeschen C. Stem cells as the root of the pancreatic ductal adenocarcinoma. Exp. Cell Res. 2012, 318:691-704.
3. Kumar-Shina C., Wei I., Simeone D.M. Emerging frontiers in pancreatic cancer research: elaboration of key genes, cells and the extracellular milieu. Curr. Opin. Gastroenterol. 2012, 28:516-522.
4. Hennig R., Ding X.Z., Adrian T.E. On the role of the islets of Langerhans in pancreatic cancer. Histol. Histopathol. 2004, 19:999-1011.
5. Matsuda Y., Kure S., Ishiwata T. Nestin and other putative cancer stem cell markers in pancreatic cancer. Med. Mol. Morphol. 2012, 45:59-65.
6. Pour P.M., Pandey K.K., Batra S.K. What is the origin of pancreatic adenocarcinoma?. Mol. Cancer 2003, 2:13-23.
7. Li C., Heidt D.G., Dalerba P., et al. Identification of pancreatic stem cells. Cancer Res. 2007, 67:1030-1037.
8. Bhagwandin V.J., Shay J.W. Pancreatic cancer stem cells: fact or fiction?. Biochim. Biophys. Acta 2009, 1792:248-259.
9. Herman P.C., Huber S.L., Herrler T., et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007, 1:313-323.
10. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer and cancer stem cells. Nature 2001, 414:105-111.
11. Clarke M.F., Dick J.E., Dirks P.B., et al. Cancer stem cells-perspectives on current status and future direction: AACR workshop on cancer stem cells. Cancer Res. 2006, 66:9339-9344.
12. Ebos J.M., Lee C.R., Cruz-Munoz W., et al. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 2009, 15:232-239.
13. Wicha M.S., Lin S., Dontu G. Cancer stem cells an old idea-a paradigm shift. Cancer Res. 2006, 66:1883-1890.
14. Chambers I., Colby D., Robertson M., et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003, 113:643-655.
15. Barker N., van Es J.H., Kuipers J., et al. Identification of stem cells in small intestine and colon by marker genes Lgr5. Nature 2007, 449:1003-1007.
16. Schepers A.G., Snippert H.J., Stange D.E., et al. Tracing reveals Lgr5 stem cell activity in mouse intestinal adenomas. Science 2012, 337:730-735.
17. Zhu Z., Kleeff J., Friess H., et al. Epiregulin is Up-regulated in pancreatic cancer and stimulates pancreatic cancer cell growth. Biochem. Biophys. Res. Commun. 2000, 273:1019-1024.
18. Amsterdam A., Raanan C., Schreiber L., et al. Localization of the stem cells markers LGR5 and Nanog in the normal and the cancerous human ovary and their inter-relationship. Acta Histochem. 2012, (Epub ahead of print). 10.1016/j.acthis.2012.09.004.
19. Pour P.M., Weide L., Liu G., et al. Experimental evidence for the origin of ductal-type adenocarcinoma from the islets of Langerhans. AJP 1997, 150:2167-2180.
20. Gidekel-Friedlander S.Y., Chu G.C., Snyder E.L., et al. Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras. Cancer Cell 2009, 16:379-389.
21. Leuskhacke M., Barker N. LGR5 and LGR6 as markers to study adult stem cell roles in self-renewal and cancer. Oncogene 2012, 31:3009-3022.
22. Liu S.H., Rao D.D., Nemunaitis J., et al. PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platform. PLoS One 2012, 7:e40452. 10.1371/journal.pone.0040452.
23. Li D. Diabetes and pancreatic cancer. Mol. Carcinog. 2012, 51:64-74.
24. Amsterdam A., Raanan C., Schreiber L., et al. Differential localization of LGR5 and Nanog in clusters of colon cancer stem cells. Acta Histochem. 2012, (Epub ahead of print). 10.1016/j.acthis.2012.09.003.